In the last three months, 6 analysts have published ratings on Travere Therapeutics (NASDAQ:TVTX), offering a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 2 | 1 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 1 | 0 | 0 | 0 |
2M Ago | 1 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 1 | 1 | 0 | 0 |
Analysts have set 12-month price targets for Travere Therapeutics, revealing an average target of $14.83, a high estimate of $19.00, and a low estimate of $9.00. Witnessing a positive shift, the current average has risen by 4.07% from the previous average price target of $14.25.
Diving into Analyst Ratings: An In-Depth Exploration
An in-depth analysis of recent...
Login or create a forever free account to read this news
Sign up/Log in